Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 7/20 | 1.00 |
| ▸ | FAAH | O00519 | 2/20 | 0.66 |
| ▸ | MGLL | Q99685 | 2/20 | 0.66 |
| ▸ | G6PD | P11413 | 1/20 | 0.58 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.55 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29678965 | 1.00 | CASP3 (1.00) | CASP3FAAHMGLLG6PDKAT2A | |
| SCHEMBL358740 | 0.85 | FAAH (0.77) | CASP3FAAHMGLLG6PDKAT2A | |
| SCHEMBL11278746 | 0.84 | CASP3 (0.74) | CASP3FAAHMGLLG6PDKAT2A | |
| SCHEMBL17948304 | 0.84 | CASP3 (0.72) | CASP3FAAHMGLLKAT2AKAT2B | |
| Alcohol SCHEMBL28664257 | 0.84 | CASP3 (0.72) | CASP3FAAHMGLLG6PDKAT2A | |
| SCHEMBL16601156 | 0.82 | FAAH (0.88) | CASP3FAAHMGLLG6PDKAT2A | |
| SCHEMBL203818 | 0.82 | FAAH (0.88) | CASP3FAAHMGLLG6PDKAT2A | |
| SCHEMBL29370720 | 0.82 | FAAH (0.88) | CASP3FAAHMGLLG6PDKAT2A | |
| SCHEMBL7630656 | 0.81 | CASP3 (0.68) | CASP3FAAHMGLLG6PDKAT2A | |
| SCHEMBL3147758 | 0.81 | FAAH (0.97) | CASP3FAAHMGLLG6PDKAT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399355-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF | Lakewood Amedex, Inc. | 2023-12-14 | — | — | US | disclosed |
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | Lakewood Amedex, Inc. (US) | 2023-10-24 | — | — | US | disclosed |
| US-20230242548-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-08-03 | — | — | US | disclosed |
| US-20230242548-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-08-03 | — | — | US | disclosed |
| WO-2023009785-A1 | TEAD INHIBITORS AND USES THEREOF | CEDILLA THERAPEUTICS, INC. (US) | 2023-02-02 | — | — | WO | disclosed |
| US-20230026056-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF | Lakewood Amedex, Inc. | 2023-01-26 | — | — | US | disclosed |
| WO-2022202958-A1 | NON-AQUEOUS SECONDARY BATTERY POLYMER COMPOSITION AND NON-AQUEOUS SECONDARY BATTERY | 旭化成株式会社 | 2022-09-29 | — | — | WO | disclosed |
| CN-111269195-B | Synthesis method for preparing saccharin | 上海交通大学 | 2022-02-25 | — | — | CN | disclosed |
| EP-3943087-A1 | HETEROARYL COMPOUNDS AND USES THEREOF | Celgene CAR LLC (BM) | 2022-01-26 | — | — | EP | disclosed |
| EP-2968337-B1 | HETEROARYL COMPOUNDS AND USES THEREOF | CELGENE CAR LLC (BM) | 2021-07-21 | — | — | EP | disclosed |
| US-5059516-A | Spectrally sensitized to near infared region with cyanine dye, (benz)isothiazole and bromo-nitro substituted alkanol | KONICA CORPORATION (JP) | 1991-10-22 | — | — | US | disclosed |
| US-5008150-A | Hydrophilic colloid, amine salt or quarternary ammonium, ester of p-hydroxybenzoic acid; improved adhesion | MITSUBISHI PAPER MILLS LIMITED (JP) | 1991-04-16 | — | — | US | disclosed |
| US-4999282-A | Layer of Spectrally Sensitized Light-Sensitive Silver Halide Emulsion | KONICA CORPORATION (JP) | 1991-03-12 | — | — | US | disclosed |
| EP-0342987-A1 | Silver halide photographic material | KONICA CORPORATION (JP) | 1989-11-23 | — | — | EP | disclosed |
| EP-0331319-A1 | Method for the formation of images | KONICA CORPORATION (JP) | 1989-09-06 | — | — | EP | disclosed |
| EP-0018100-B1 | SUBSTITUTED AROMATIC BIOLOGICALLY ACTIVE COMPOUND, A PROCESS FOR ITS PREPARATION AND ITS USE AS BIOCIDE | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-01-18 | — | — | EP | disclosed |
| US-4396413-A | BACTERICIDES, FUNGICIDES, ALGICIDES | ROHM AND HAAS COMPANY (US) | 1983-08-02 | — | — | US | disclosed |
| US-4241214-A | BACTERICIDE, FUNGICIDE AND ALGAECIDE | ROHM AND HAAS COMPANY (US) | 1980-12-23 | — | — | US | disclosed |
| US-4150026-A | BACTERICIDES, FUNGICIDES, ALGICIDES | ROHM AND HAAS COMPANY (US) | 1979-04-17 | — | — | US | disclosed |
| US-4062946-A | 3-ISOTHIAZOLONES | ROHM AND HAAS COMPANY (US) | 1977-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026056-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF | CAT, MPO, NISCH | CASP3 279/4885FAAH 3823/4885MGLL 509/4885 |
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | CAT, MPO, NISCH | CASP3 279/4885FAAH 3823/4885MGLL 509/4885 |
| US-20230242548-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | KRAS, HRAS, NRAS | CASP3 919/4885FAAH 3508/4885MGLL 2601/4885 |
| US-20230399355-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF | CAT, MPO, NISCH | CASP3 279/4885FAAH 3823/4885MGLL 509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.